April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
OCTN2 Mediates Active Transport of L-Carnitine in Human Corneal and Conjunctival Epithelial Cells
Author Affiliations & Notes
  • J. L. Flanagan
    Institute for Eye Research, Sydney, Australia
  • S. Xu
    Institute for Eye Research, Sydney, Australia
  • P. A. Simmons
    Allergan, Inc, Irvine, California
  • J. G. I. Vehige, Jr.
    Allergan, Inc, Irvine, California
  • M. D. Willcox
    Institute for Eye Research, Sydney, Australia
    School of Optometry and Vision Science, University of New South Wales, Sydney, Australia
  • Q. Garrett
    Institute for Eye Research, Sydney, Australia
    School of Optometry and Vision Science, University of New South Wales, Sydney, Australia
  • Footnotes
    Commercial Relationships  J.L. Flanagan, None; S. Xu, None; P.A. Simmons, Allergan, E; J.G.I. Vehige, Jr., Allergan, E; M.D. Willcox, Allergan, C; Q. Garrett, Allergan, C.
  • Footnotes
    Support  Grants from the Institute for Eye research and Allergan Inc
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2364. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. L. Flanagan, S. Xu, P. A. Simmons, J. G. I. Vehige, Jr., M. D. Willcox, Q. Garrett; OCTN2 Mediates Active Transport of L-Carnitine in Human Corneal and Conjunctival Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2364.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Imbalance of L-Carnitine (β-hydroxy-gamma-trimethylaminobutyrate) levels has been implicated in ocular surface damage of dry eye syndrome. Previously we demonstrated expression and localization of carnitine/organic cation transporters, OCTN1 and OCTN2, in human corneal and conjunctival epithelia. The present study aimed to characterize L-carnitine transport in cultured human limbal corneal (HCLE) and conjunctival epithelial (HCjE) cells.

Methods: : Time-course, Na+ dependence, kinetics, and pH- dependence of L-carnitine transport were investigated using L-[3H]carnitine uptake in HCLE and HCjE cells. The effect of D-carnitine, acetyl-L-carnitine, γ-butyrobetaine, tetraethylammonium (TEA), 2-amino-2-norbornane carboxylic acid (BCH) and the blocking effect of OCTN1 and/or OCTN2 specific antibodies on the uptake of L-[3H]carnitine by cells were determined.

Results: : L-[3H]carnitine uptake in both HCLE and HCjE cells increased in a linear, time-dependent manner, beyond 90 min. Choline replacement of Na+ in the uptake buffer inhibited by 90% (p = 0.001).Uptake was saturable and linear (1-24 µM). A low and high affinity transport system was observed for both cell lines. Differences in Km and Vmax for L-carnitine transport were significant: Km 33.9 ± 12.7 vs. 18.9 ± 5.3 (high) and 216.7 ± 44.4 vs.172.3 ± 37.1 (low); Vmax 1.1 ± 0.3 vs. 0.5± 0.1 (high) and 3.5 ± 0.3 and 1.99 ± 0.2 (low) for HCLE and HCjE respectively. L-carnitine, D-carnitine, acetyl-L-Carnitine and γ-butyrobetaine inhibited the uptake of L-[3H]carnitine by HCLE and HCjE cells. L-carnitine was showed stronger inhibition than D-carnitine and acetyl-L-carnitine (p < 0.01); gamma-butyrobetaine was equal to L-carnitine. There was no difference between D-carnitine and acetyl-L-carnitine. Inhibition was concentration dependent. L-[3H]carnitine uptake was highest pH 5.5. Anti-OCTN2 antibodies blocked transport.

Conclusions: : L-carnitine enters HCLE and HCjE cells by active carrier transport which is time-, Na+-, and pH- dependent. OCTN2 appears to play a dominant role in this process.

Keywords: cornea: tears/tear film/dry eye • cornea: epithelium • protective mechanisms 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×